Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Importance of Complement-Mediated Immune Signaling in Alzheimer’s Disease Pathogenesis
André F. Batista, Khyrul Khan, Maria-Tzousi Papavergi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 817-817
Open Access | Times Cited: 22

Showing 22 citing articles:

Amyloid-related imaging abnormalities: manifestations, metrics and mechanisms
Steven M. Greenberg, Francesco Bax, Susanne J. van Veluw
Nature Reviews Neurology (2025)
Closed Access | Times Cited: 3
Comparison of the amyloid plaque proteome in Down syndrome, early-onset Alzheimer’s disease, and late-onset Alzheimer’s disease
Mitchell Martà-Ariza, Dominique Leitner, Evgeny Kanshin, et al.
Acta Neuropathologica (2025) Vol. 149, Iss. 1
Open Access | Times Cited: 1
The Impact of Anti-Amyloid Immunotherapies on Stroke Care
Philippe‐Antoine Bilodeau, John R. Dickson, Mariel G. Kozberg
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1245-1245
Open Access | Times Cited: 8
Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer’s Disease
Eunshil Lee, Yongmin Chang
Cells (2025) Vol. 14, Iss. 3, pp. 168-168
Open Access
Senescent microglia: The hidden culprits accelerating Alzheimer’s disease
Li Wu, Xie Yong-Yan, Mu Jia-Xin, et al.
Brain Research (2025), pp. 149480-149480
Closed Access
Synapse vulnerability and resilience underlying Alzheimer’s disease
Raquel N. Taddei, Karen Duff
EBioMedicine (2025) Vol. 112, pp. 105557-105557
Open Access
Altered Clearance and Amyloid-Related Imaging Abnormalities
Petrice M. Cogswell, Brian J. Burkett, Derek R. Johnson, et al.
Neuroimaging Clinics of North America (2025)
Closed Access
Astrocyte-neuron communication through the complement C3-C3aR pathway in Parkinson’s disease
Xiaosa Chi, Sijia Yin, Yadi Sun, et al.
Brain Behavior and Immunity (2024)
Open Access | Times Cited: 4
Amyloid-Related Imaging Abnormalities in Clinical Trials of Gantenerumab in Early Alzheimer Disease
Stephen Salloway, Jakub Wojtowicz, Nicola Voyle, et al.
JAMA Neurology (2024) Vol. 82, Iss. 1, pp. 19-19
Open Access | Times Cited: 4
Beneficial versus Detrimental Effects of Complement-Microglial Interactions in Alzheimer’s Disease
Gunel Ayyubova, Nadeem Fazal
(2024)
Open Access | Times Cited: 1
Beneficial versus Detrimental Effects of Complement-Microglial Interactions in Alzheimer’s Disease
Gunel Ayyubova, Nadeem Fazal
(2024)
Open Access | Times Cited: 1
Beneficial versus Detrimental Effects of Complement–Microglial Interactions in Alzheimer’s Disease
Gunel Ayyubova, Nadeem Fazal
Brain Sciences (2024) Vol. 14, Iss. 5, pp. 434-434
Open Access | Times Cited: 1
Early signs of neurodegenerative diseases: Possible mechanisms and targets for Golgi stress
Mengyu Liu, Ying Duan, Jianru Dong, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116646-116646
Open Access | Times Cited: 1
Complement C3aR signaling: Immune and metabolic modulation and its impact on Alzheimer's disease
Manasee Gedam, Hui Zheng
European Journal of Immunology (2024) Vol. 54, Iss. 8
Open Access | Times Cited: 1
Axon length-dependent synapse loss is mediated by neuronal cytokine-induced glial phagocytosis
Federico Tenedini, Chang Yin, Jessica Huang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Repurposing FDA-Approved Drugs Against Potential Drug Targets Involved in Brain Inflammation Contributing to Alzheimer’s Disease
Catherine Sharo, Jilei Zhang, Tianhua Zhai, et al.
Targets (2024) Vol. 2, Iss. 4, pp. 446-469
Open Access
Progress of Chinese Medicine in Regulating Microglial Polarization against Alzheimer’s Disease
Fengge Yang, Wei Gao, J Z Wang, et al.
The American Journal of Chinese Medicine (2024), pp. 1-21
Closed Access
Aged AβPPswe/PS1ΔE9 mice as a useful animal model for studying the link between immunological senescence and diseases
Jing Luan, Na Guo, Fengrui Hu, et al.
Immunology Letters (2024) Vol. 266, pp. 106842-106842
Closed Access
Comparison of the Amyloid Plaque Proteome in Down Syndrome, Early-Onset Alzheimer’s Disease and Late-Onset Alzheimer’s Disease
Mitchell Martà-Ariza, Dominique Leitner, Evgeny Kanshin, et al.
Research Square (Research Square) (2024)
Open Access
Discovery of plasma biomarkers related to blood-brain barrier dysregulation in Alzheimer’s disease
Yuet Ruh Dan, Keng‐Hwee Chiam
Frontiers in Bioinformatics (2024) Vol. 4
Open Access
Altered immune response is associated with sex difference in vulnerability to Alzheimer's disease in human prefrontal cortex
Huiying Wen, Youzhe He, Yuanchun Tang, et al.
Brain Pathology (2024)
Open Access
Alzheimer’s Disease: In Vitro and In Vivo Evidence of Activation of the Plasma Bradykinin-Forming Cascade and Implications for Therapy
Allen P. Kaplan, Berhane Ghebrehiwet, Kusumam Joseph
Cells (2024) Vol. 13, Iss. 24, pp. 2039-2039
Open Access
Page 1

Scroll to top